3Z uses advanced disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders.
Employees: 11-50
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Nýsköpunar... | nyskopun.i... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 18.08.2023 | 3Z and biotx.ai Forge Partnership to Advance ADHD Drug Devel... | REYKJAVIK, Iceland and BERLIN, Aug. 18, 2023 /PRNewswire/ -- Reykjavik-based drug discovery company,... | en.prnasia... |
| 22.11.2022 | 3Z: Zebrafish mutant model reveals novel drug candidates for... | REYKJAVIK, Iceland, Nov. 22, 2022 /PRNewswire/ -- ADHD is a highly prevalent neurodevelopmental diso... | einpresswi... |
| 22.11.2022 | 3Z: Zebrafish mutant model reveals novel drug candidates for... | REYKJAVIK, Iceland, Nov. 22, 2022 /PRNewswire/ -- ADHD is a highly prevalent neurodevelopmental diso... | en.prnasia... |
| 21.11.2022 | Zebrafish mutant model reveals novel drug candidates for ADH... | Zebrafish mutant model reveals novel drug candidates for ADHD Mon, Nov 21, 2022 20:15 CET Report th... | news.cisio... |
| 20.06.2022 | 3Z closes $2 million funding for preclinical development of ... | 3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics ide... | news.cisio... |
| 20.06.2022 | 3Z closes $2 million funding for preclinical development of ... | REYKJAVIK, Iceland, June 20, 2022 /PRNewswire/ -- 3Z, a Reykjavik based drug discovery company is pl... | en.prnasia... |
| 20.06.2022 | 3Z Closes $2M Funding | 3Z, a Reykjavik, Iceland-based drug discovery company, closed a $2m funding round. The backers were... | finsmes.co... |